Cable Hill Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-80
Closed -$4K 1000
2017
Q3
$4K Sell
80
-2
-2% -$100 ﹤0.01% 827
2017
Q2
$5K Hold
82
﹤0.01% 558
2017
Q1
$6K Buy
82
+46
+128% +$3.37K ﹤0.01% 506
2016
Q4
$3K Sell
36
-52
-59% -$4.33K ﹤0.01% 623
2016
Q3
$6K Buy
88
+31
+54% +$2.11K ﹤0.01% 536
2016
Q2
$3K Hold
57
﹤0.01% 593
2016
Q1
$4K Hold
57
﹤0.01% 519
2015
Q4
$7K Hold
57
0.01% 421
2015
Q3
$6K Buy
+57
New +$6K ﹤0.01% 467